Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1982-03-01
1983-05-10
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125LH, A61K 3700, C07C10352
Patent
active
043829228
ABSTRACT:
LRF analogs having a modified D-Phe residue in the 6-position act as superagonists exhibiting potencies many times more than that of LRF. The peptides or their nontoxic salts can be administered by intravenous, subcutaneous, sublingual, oral, intravaginal, intranasal or rectal routes. The peptides can be used to regulate fertility in male and female mammals, including human beings.
The peptides are represented by the following formula:
REFERENCES:
patent: 4234571 (1980-11-01), Nestor et al.
Rivier Jean E. F.
Vale, Jr. Wylie W.
Phillips Delbert R.
The Salk Institute for Biological Studies
LandOfFree
Peptides affecting gonadal function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides affecting gonadal function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides affecting gonadal function will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-525854